TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
RLAY

Relay Therapeutics Inc

Healthcare · Biotechnology

18.80$ -1.8% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

Relay Therapeutics Inc (RLAY) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 621 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet RLAY
Line item 2018 2019 2020 2021 2022 2023 2024 2025
429 393 800 1,008 1,100 844 871 621
424 361 770 976 1,020 770 809 578
422 42 448 280 152 144 124 84
422 356 678 958 999 750 781 555
83 4.9 5.2 0.0
-238 -682 12
3.6 32 29 6.5 12
2.3 2.3 2.3 2.3
540 574 37 111 150 92 94 54
6.9 12 14 24 64 30 51 26
0.2 1.2 1.5 1.8 4.3 5.0 5.7 3.8
4.7 7.0 6.4 8.3 11 9.2 14 7.7
-111 -180 763 898 950 752 778 567
-114 -189 -404 -768 -1,059 -1,401 -1,738 -2,015
2.5 4.3 90 95 112 123 143 172

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?